AHEAD Medicine is a startup focusing on developing AI-enabled diagnostic and clinical decision support tools for blood cancer management. Unlike other chronic diseases, diagnosis and clinical decision delay or misdirection can be catastrophic for blood cancer, sometimes leading to death.
Our first and leading product is AHEAD-flow platform, the automated clinical flow cytometry analysis tool for blood cancer triage. AHEAD has gathered and curated real-world blood cancer flow cytometry dataset from National Taiwan University Hospital and University of Pittsburgh Medical Center. It provides fully automated analytical results without labor-intensive assignments on unclassified subgroups and can be applied with any flow cytometry reagents and instruments. Moreover, AHEAD-flow is the fastest triage tool with average of 7 seconds analysis time per specimen, more than 100 times faster than other currently available options.
With AHEAD-flow solution, physicians could identify abnormal cases sooner and prioritize subsequent clinical actions, and indirectly support optimizing treatment outcome. Furthermore, AHEAD-flow could also increase the service capacity for the flow laboratory via workflow optimization and unplug the analysis bottleneck.